Jingming Capital is an investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 29, 2022
Yingsheng Biology
|
Series C | — | Biotechnology | — |
Jan 25, 2022
Tongxin Medical Equipment
|
Series D | $100M | Biotechnology | — |
Jan 21, 2022
SiBionics
|
Series C | $126M | Artificial Intelligence | — |
Oct 8, 2021
ChosenMed
|
Series C | — | Health Care | — |